Kodiak Turns Back On Tarcocimab After Two Pivotal Trial Flops In DME

Stock Down 46%

 
• By Ayisha Sharma
  
white arrow on road pointing towards dead-end brick wall
It Is The End Of The Road For Kodiak's Tarcocimab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D